Eckert & Ziegler SE is a holding company, which engages in the processing of radio isotopes. It also focuses on the development, production, and sale of isotope technology components and related products. It operates through the following segments: Isotope Products, Medical, and Other. The Isotope Products segment manufactures and distributes standards, and radiation sources for medical and industrial purposes. The Medical segment offers small radioactive implants for treating prostate cancer and eye applications for treating uveal melanoma. The Other segment focuses pools internal group services like radiation protection, legal, accounting, information technology, and human resources. The company was founded by Andreas Eckert in 1997 and is headquartered in Berlin, Germany.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company